1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Upper Street Marketing Inc.

Upper Street Marketing Inc.

UPPR
Upper Street Marketing Inc.US flagOther OTC
0.00
USD
- -
- -
7,995.00Market Cap
Upper Street Marketing Inc.
UPPR
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

1999
2000
2001
2002
2003
2004
TTM
FRC
72.96
80.94
75.78
85.46
93.86
- -
93.07
Revenue per Share
-1.9
-8.29
-5.9
4.34
-0.18
- -
-3.09
Basic EPS, GAAP
-6.09
2.19
4.65
-1.57
4.32
- -
3.71
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
23.13
21.63
15.74
20.07
19.89
16.8
16.8
Book Value per Share
23.13
21.63
15.74
20.07
19.89
16.8
16.8
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
6
7
6
7
8
8
8
Sales/Revenue/Turnover
0.16
-8.42
-1.51
8.67
1.11
-1.53
-1.53
Operating Margin (%)
1
1
1
1
1
1
1
Depreciation Expense
- -
-1
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-2.6
-10.24
-7.78
5.07
-0.2
-3.32
-3.32
Profit Margin (%)
- -
- -
- -
1
- -
1
1
Working Capital
4
4
3
4
4
4
4
LT Debt
2
2
1
2
2
1
1
Total Equity
- -
- -
- -
10.03
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-37.62
-31.56
24.22
-0.92
-16.84
-16.84
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'04
Sep'04
Dec'04
ST Debt
- -
- -
- -
LT Borrowings
4
4
4
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
- -
Market Capitalization
- -
- -
2

Working Capital

FRC

•

in mil. unless spec.
Jun'04
Sep'04
Dec'04
Total Current Assets
2
3
2
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
1
1
1
Inventories
1
1
1
Total Current Liabilities
1
1
2
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-3.85%
-15.53%
Free Cash Flow
- -
-109.34%
-14.11%
Net Income, GAAP
- -
323.74%
1,574.15%
Sales/Revenue/Turnover
- -
6.06%
-0.84%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2002
3
2
1
1
7
2003
3
2
1
1
8
2004
3
2
1
1
8

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2002
6.45
3.6
-2.15
- -
4.34
2003
5.8
2.51
-5.56
- -
-0.18
2004
3.07
2.25
-1.37
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2002
- -
- -
- -
- -
- -
2003
- -
- -
- -
- -
- -
2004
- -
- -
- -
- -
- -
Similar Companies
Burzynski Research Institute, Inc. (BZYR)
GuiZhou SanLi Pharmaceutical Co.,Ltd (603439.SS)
MDxHealth S.A. (0O8G.L)
Coral Laboratories Limited (CORALAB.BO)
Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS)
Leafly Holdings, Inc. (LFLYW)
Business
Upper Street Marketing Inc. identifies and acquires distinct businesses demonstrating strong growth prospects. The company currently focuses its acquisition efforts on specialty and craft distilleries within the tequila and vodka markets, alongside innovative firms in the medical technology sector. It maintains its corporate presence in Scottsdale, Arizona.

Company News

Company News APIChatGPT

  • globenewswire.com

    Union Power Metals Confirms Upcoming Drill Program at Slovakia Manganese Projects